Learn / GALT
NASDAQ: GALT
Galectin Therapeutics (GALT) stock, explained like you're 5
Galectin Therapeutics trades on the Nasdaq under the ticker GALT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 398 million dollars.
- Ticker
- GALT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 398 million dollars
Is Galectin Therapeutics a small, medium or large cap company?
No. Galectin Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 398 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Galectin Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves GALT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Galectin Therapeutics (NASDAQ:GALT) Stock Price Breaks Above 200 Day Moving Average Here's Why (MarketBeat)
- GALECTIN THERAPEUTICS INC SEC Filing (Oct 13, 2026) (Stock Titan)
- Galectin Therapeutics stock has November 13 earnings, USD 0.05 estimate (ad-hoc-news.de)
- GALT Jumps 11% on FDA Alignment for Belapectin Phase III Path in MASH (Yahoo Finance)
- Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Common Stock by Chairman Richard E. Uihlein (Quiver Quantitative)
Follow GALT in your daily brief
Each trading day at 5 PM ET we post what happened to Galectin Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow GALT
Questions about Galectin Therapeutics stock
What does Galectin Therapeutics do?
Galectin Therapeutics trades on the Nasdaq under the ticker GALT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 398 million dollars.
What is the ticker symbol for Galectin Therapeutics?
Galectin Therapeutics trades under the ticker GALT on the Nasdaq.
What is Galectin Therapeutics's market cap?
Galectin Therapeutics is a small cap stock with a market cap of about 398 million dollars.
How does Galectin Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves GALT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow GALT stock every day?
Add GALT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.